Hiroko Kunitake1,2, Marcia M Russell3,4, Ping Zheng5, Greg Yothers5,6,7, Stephanie R Land8, Laura Petersen9, Louis Fehrenbacher10, Jeffery K Giguere11, D Lawrence Wickerham1,12, Clifford Y Ko1,13, Patricia A Ganz1,14. 1. National Surgical Adjuvant Breast and Bowel Project (NSABP)/NRG Oncology, Pittsburgh, PA, USA. 2. Boston University School of Medicine, Boston, MA, USA. 3. National Surgical Adjuvant Breast and Bowel Project (NSABP)/NRG Oncology, Pittsburgh, PA, USA. Marcia.Russell2@va.gov. 4. David Geffen School of Medicine at UCLA, VA Greater Los Angeles Healthcare System, 11301 Wilshire Boulevard, Mail Code 10H2, Los Angeles, CA, 90073, USA. Marcia.Russell2@va.gov. 5. Department of Health Policy and Management, The University of Pittsburgh, Pittsburgh, PA, USA. 6. The University of Pittsburgh, Pittsburgh, PA, USA. 7. NRG Oncology, Pittsburgh, PA, USA. 8. National Cancer Institute, Bethesda, MD, USA. 9. UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. 10. Kaiser Permanente Oncology Clinical Trials Northern California, Vallejo, CA, USA. 11. Greenville Health System Cancer Institute, Greenville, SC, USA. 12. Allegheny Health Network Cancer Institute, Pittsburgh, PA, USA. 13. David Geffen School of Medicine at UCLA, VA Greater Los Angeles Healthcare System, 11301 Wilshire Boulevard, Mail Code 10H2, Los Angeles, CA, 90073, USA. 14. UCLA Schools of Medicine and Public Health and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA.
Abstract
PURPOSE: Little is known about health-related quality of life (HRQL) in long-term survivors (LTS) of colorectal cancer (CRC). METHODS: Long-term CRC survivors (≥5 years) treated in previous National Surgical Adjuvant Breast and Bowel Project trials were recruited from 60 sites. After obtaining consent, a telephone survey was administered, which included HRQL instruments to measure physical health (Instrumental Activities of Daily Living [IADL], SF-12 Physical Component Scale [PCS], SF-36 Vitality Scale), mental health (SF-12 Mental Component Scale [MCS], Life Orientation Test, and Impact of Cancer), and clinical symptoms (Fatigue Symptom Inventory [FSI], European Organization for Research and Treatment of Cancer Colorectal Module [EORTC-CR38], and Brief Pain Inventory). A multivariable model identified predictors of overall quality of life (global health rating). RESULTS: Participants (N = 708) had significantly higher HRQL compared with age group-matched non-cancer controls with higher mean scores on SF-12 PCS (49.5 vs. 43.7, p = <0.05), MCS (55.6 vs. 52.1, p = <0.05), and SF-36 Vitality Scale (67.1 vs. 59.9, p = <0.05). Multivariable modeling has demonstrated that better overall physical and mental health (PCS and MCS), positive body image (EORTC-CR38 scale), and less fatigue (FSI), were strongly associated with overall quality of life as measured by the global health rating. Interestingly, ability to perform IADLs, experience of cancer, gastrointestinal complaints, and pain, were not important predictors. CONCLUSIONS: In long-term CRC survivors, overall physical and mental health was excellent compared with general population. Other disease-related symptoms did not detract from good overall health. IMPLICATIONS FOR CANCER SURVIVORS: LTS of CRC within the setting of a clinical trial have higher HRQL than the general population, and treatment regimens do not appear to be associated with any significant late effects on quality of life. TRIAL REGISTRATION: NSABP LTS-01: NCT00410579.
PURPOSE: Little is known about health-related quality of life (HRQL) in long-term survivors (LTS) of colorectal cancer (CRC). METHODS: Long-term CRC survivors (≥5 years) treated in previous National Surgical Adjuvant Breast and Bowel Project trials were recruited from 60 sites. After obtaining consent, a telephone survey was administered, which included HRQL instruments to measure physical health (Instrumental Activities of Daily Living [IADL], SF-12 Physical Component Scale [PCS], SF-36 Vitality Scale), mental health (SF-12 Mental Component Scale [MCS], Life Orientation Test, and Impact of Cancer), and clinical symptoms (Fatigue Symptom Inventory [FSI], European Organization for Research and Treatment of Cancer Colorectal Module [EORTC-CR38], and Brief Pain Inventory). A multivariable model identified predictors of overall quality of life (global health rating). RESULTS:Participants (N = 708) had significantly higher HRQL compared with age group-matched non-cancer controls with higher mean scores on SF-12 PCS (49.5 vs. 43.7, p = <0.05), MCS (55.6 vs. 52.1, p = <0.05), and SF-36 Vitality Scale (67.1 vs. 59.9, p = <0.05). Multivariable modeling has demonstrated that better overall physical and mental health (PCS and MCS), positive body image (EORTC-CR38 scale), and less fatigue (FSI), were strongly associated with overall quality of life as measured by the global health rating. Interestingly, ability to perform IADLs, experience of cancer, gastrointestinal complaints, and pain, were not important predictors. CONCLUSIONS: In long-term CRC survivors, overall physical and mental health was excellent compared with general population. Other disease-related symptoms did not detract from good overall health. IMPLICATIONS FOR CANCER SURVIVORS: LTS of CRC within the setting of a clinical trial have higher HRQL than the general population, and treatment regimens do not appear to be associated with any significant late effects on quality of life. TRIAL REGISTRATION: NSABP LTS-01: NCT00410579.
Entities:
Keywords:
Colorectal cancer; Quality of life; Survivors
Authors: Barry C Lembersky; H Samuel Wieand; Nicholas J Petrelli; Michael J O'Connell; Linda H Colangelo; Roy E Smith; Thomas E Seay; Jeffrey K Giguere; M Ernest Marshall; Andrew D Jacobs; Lauren K Colman; Atilla Soran; Greg Yothers; Norman Wolmark Journal: J Clin Oncol Date: 2006-05-01 Impact factor: 44.544
Authors: Olga Husson; Floortje Mols; Lonneke van de Poll-Franse; Jolanda de Vries; Goof Schep; Melissa S Y Thong Journal: Support Care Cancer Date: 2015-01-06 Impact factor: 3.603
Authors: Jacek A Kopec; Greg Yothers; Patricia A Ganz; Stephanie R Land; Reena S Cecchini; H Samuel Wieand; Barry C Lembersky; Norman Wolmark Journal: J Clin Oncol Date: 2007-02-01 Impact factor: 44.544
Authors: N Wolmark; H S Wieand; D M Hyams; L Colangelo; N V Dimitrov; E H Romond; M Wexler; D Prager; A B Cruz; P H Gordon; N J Petrelli; M Deutsch; E Mamounas; D L Wickerham; E R Fisher; H Rockette; B Fisher Journal: J Natl Cancer Inst Date: 2000-03-01 Impact factor: 13.506
Authors: Mark S Roh; Linda H Colangelo; Michael J O'Connell; Greg Yothers; Melvin Deutsch; Carmen J Allegra; Morton S Kahlenberg; Luis Baez-Diaz; Carol S Ursiny; Nicholas J Petrelli; Norman Wolmark Journal: J Clin Oncol Date: 2009-09-21 Impact factor: 44.544
Authors: Julienne E Bower; Kate Bak; Ann Berger; William Breitbart; Carmelita P Escalante; Patricia A Ganz; Hester Hill Schnipper; Christina Lacchetti; Jennifer A Ligibel; Gary H Lyman; Mohammed S Ogaily; William F Pirl; Paul B Jacobsen Journal: J Clin Oncol Date: 2014-04-14 Impact factor: 44.544
Authors: Patricia A Ganz; Stephanie R Land; Cynthia Antonio; Ping Zheng; Greg Yothers; Laura Petersen; D Lawrence Wickerham; N Wolmark; Clifford Y Ko Journal: J Cancer Surviv Date: 2009-06-13 Impact factor: 4.442
Authors: Renate M Winkels; Kathleen M Sturgeon; Michael J Kallan; Lorraine T Dean; Zi Zhang; Margaret Evangelisti; Justin C Brown; David B Sarwer; Andrea B Troxel; Crystal Denlinger; Monica Laudermilk; Anna Fornash; Angela DeMichele; Lewis A Chodosh; Kathryn H Schmitz Journal: Contemp Clin Trials Date: 2017-07-21 Impact factor: 2.226
Authors: Shane Lloyd; David Baraghoshi; Randa Tao; Ignacio Garrido-Laguna; Glynn W Gilcrease; Jonathan Whisenant; John R Weis; Courtney Scaife; Thomas B Pickron; Lyen C Huang; Marcus M Monroe; Sarah Abdelaziz; Alison M Fraser; Ken R Smith; Vikrant Deshmukh; Michael Newman; Kerry G Rowe; John Snyder; Niloy J Samadder; Mia Hashibe Journal: Am J Clin Oncol Date: 2019-04 Impact factor: 2.339
Authors: Caroline W Cohen; Kevin R Fontaine; Rebecca C Arend; Taraneh Soleymani; Barbara A Gower Journal: Nutrients Date: 2018-08-30 Impact factor: 5.717
Authors: Victoria M White; Karolina Lisy; Andrew Ward; Eli Ristevski; Melanie Clode; Kate Webber; Jon Emery; Maarten J Ijzerman; Nina Afshar; Jeremy Millar; Peter Gibbs; Sue Evans; Michael Jefford Journal: Support Care Cancer Date: 2022-03-12 Impact factor: 3.359